More companies need to set diversity enrollment goals in cancer trials, FDA says
The FDA released draft guidance back in April 2022 recommending that biopharma sponsors voluntarily submit plans to explain how they plan to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
